MiR-31 could promote cardiac hypertrophy through targeting protein kinase C epsilon (PKCε), which has been shown to blunt cardiac pathophysiologic responses in response to chronic hypoxia by a HIF-1a-mediated mechanism [71]. The gene discussed is PRKCE; the disease is cardiac hypertrophy.